Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves
dc.contributor.author | Bleiziffer, Sabine | |
dc.contributor.author | Simonato, Matheus | |
dc.contributor.author | Webb, John G | |
dc.contributor.author | Rodés-Cabau, Josep | |
dc.contributor.author | Pibarot, Philippe | |
dc.contributor.author | Kornowski, Ran | |
dc.contributor.author | Windecker, Stephan | |
dc.contributor.author | Erlebach, Magdalena | |
dc.contributor.author | Duncan, Alison | |
dc.contributor.author | Seiffert, Moritz | |
dc.contributor.author | Unbehaun, Axel | |
dc.contributor.author | Frerker, Christian | |
dc.contributor.author | Conzelmann, Lars | |
dc.contributor.author | Wijeysundera, Harindra | |
dc.contributor.author | Kim, Won-Keun | |
dc.contributor.author | Montorfano, Matteo | |
dc.contributor.author | Latib, Azeem | |
dc.contributor.author | Tchetche, Didier | |
dc.contributor.author | Allali, Abdelhakim | |
dc.contributor.author | Abdel-Wahab, Mohamed | |
dc.contributor.author | Orvin, Katia | |
dc.contributor.author | Stortecky, Stefan | |
dc.contributor.author | Nissen, Henrik | |
dc.contributor.author | Holzamer, Andreas | |
dc.contributor.author | Urena, Marina | |
dc.contributor.author | Testa, Luca | |
dc.contributor.author | Agrifoglio, Marco | |
dc.contributor.author | Whisenant, Brian | |
dc.contributor.author | Sathananthan, Janarthanan | |
dc.contributor.author | Napodano, Massimo | |
dc.contributor.author | Landi, Antonio | |
dc.contributor.author | Fiorina, Claudia | |
dc.contributor.author | Zittermann, Armin | |
dc.contributor.author | Veulemans, Verena | |
dc.contributor.author | Sinning, Jan-Malte | |
dc.contributor.author | Saia, Francesco | |
dc.contributor.author | Brecker, Stephen | |
dc.contributor.author | Presbitero, Patrizia | |
dc.contributor.author | De Backer, Ole | |
dc.contributor.author | Søndergaard, Lars | |
dc.contributor.author | Bruschi, Giuseppe | |
dc.contributor.author | Franco, Luis Nombela | |
dc.contributor.author | Petronio, Anna Sonia | |
dc.contributor.author | Barbanti, Marco | |
dc.contributor.author | Cerillo, Alfredo | |
dc.contributor.author | Spargias, Konstantinos | |
dc.contributor.author | Schofer, Joachim | |
dc.contributor.author | Cohen, Mauricio | |
dc.contributor.author | Muñoz-Garcia, Antonio | |
dc.contributor.author | Finkelstein, Ariel | |
dc.contributor.author | Adam, Matti | |
dc.contributor.author | Serra, Vicenç | |
dc.contributor.author | Teles, Rui Campante | |
dc.contributor.author | Champagnac, Didier | |
dc.contributor.author | Iadanza, Alessandro | |
dc.contributor.author | Chodor, Piotr | |
dc.contributor.author | Eggebrecht, Holger | |
dc.contributor.author | Welsh, Robert | |
dc.contributor.author | Caixeta, Adriano | |
dc.contributor.author | Salizzoni, Stefano | |
dc.contributor.author | Dager, Antonio | |
dc.contributor.author | Auffret, Vincent | |
dc.contributor.author | Cheema, Asim | |
dc.contributor.author | Ubben, Timm | |
dc.contributor.author | Ancona, Marco | |
dc.contributor.author | Rudolph, Tanja | |
dc.contributor.author | Gummert, Jan | |
dc.contributor.author | Tseng, Elaine | |
dc.contributor.author | Noble, Stephane | |
dc.contributor.author | Bunc, Matjaz | |
dc.contributor.author | Roberts, David | |
dc.contributor.author | Kass, Malek | |
dc.contributor.author | Gupta, Anuj | |
dc.contributor.author | Leon, Martin B | |
dc.contributor.author | Dvir, Danny | |
dc.date.accessioned | 2020-08-17T16:57:42Z | |
dc.date.available | 2020-08-17T16:57:42Z | |
dc.date.issued | 2020-08-01 | |
dc.identifier.uri | http://hdl.handle.net/10713/13558 | |
dc.description.abstract | AIMS: Due to bioprosthetic valve degeneration, aortic valve-in-valve (ViV) procedures are increasingly performed. There are no data on long-term outcomes after aortic ViV. Our aim was to perform a large-scale assessment of long-term survival and reintervention after aortic ViV. METHODS AND RESULTS: A total of 1006 aortic ViV procedures performed more than 5 years ago [mean age 77.7 ± 9.7 years; 58.8% male; median STS-PROM score 7.3% (4.2-12.0)] were included in the analysis. Patients were treated with Medtronic self-expandable valves (CoreValve/Evolut, Medtronic Inc., Minneapolis, MN, USA) (n = 523, 52.0%), Edwards balloon-expandable valves (EBEV, SAPIEN/SAPIEN XT/SAPIEN 3, Edwards Lifesciences, Irvine, CA, USA) (n = 435, 43.2%), and other devices (n = 48, 4.8%). Survival was lower at 8 years in patients with small-failed bioprostheses [internal diameter (ID) ≤ 20 mm] compared with those with large-failed bioprostheses (ID > 20 mm) (33.2% vs. 40.5%, P = 0.01). Independent correlates for mortality included smaller-failed bioprosthetic valves [hazard ratio (HR) 1.07 (95% confidence interval (CI) 1.02-1.13)], age [HR 1.21 (95% CI 1.01-1.45)], and non-transfemoral access [HR 1.43 (95% CI 1.11-1.84)]. There were 40 reinterventions after ViV. Independent correlates for all-cause reintervention included pre-existing severe prosthesis-patient mismatch [subhazard ratio (SHR) 4.34 (95% CI 1.31-14.39)], device malposition [SHR 3.75 (95% CI 1.36-10.35)], EBEV [SHR 3.34 (95% CI 1.26-8.85)], and age [SHR 0.59 (95% CI 0.44-0.78)]. CONCLUSIONS: The size of the original failed valve may influence long-term mortality, and the type of the transcatheter valve may influence the need for reintervention after aortic ViV. Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. | en_US |
dc.description.uri | https://doi.org/10.1093/eurheartj/ehaa544 | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Oxford University Press | en_US |
dc.relation.ispartof | European Heart Journal | en_US |
dc.rights | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. | en_US |
dc.subject | Aortic valve-in-valve | en_US |
dc.subject | Reintervention | en_US |
dc.subject | SAPIEN valve | en_US |
dc.subject | Severe prosthesis–patient mismatch | en_US |
dc.subject | TAVR | en_US |
dc.title | Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1093/eurheartj/ehaa544 | |
dc.identifier.pmid | 32592401 | |
dc.source.volume | 41 | |
dc.source.issue | 29 | |
dc.source.beginpage | 2731 | |
dc.source.endpage | 2742 | |
dc.source.country | England |